Two Sigma Advisers’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $153K | Buy |
40,700
+25,900
| +175% | +$97.6K | ﹤0.01% | 2161 |
|
|
2025
Q1 | $67K | Sell |
14,800
-14,900
| -50% | -$67.5K | ﹤0.01% | 2290 |
|
|
2024
Q4 | $210K | Buy |
29,700
+12,500
| +73% | +$88.4K | ﹤0.01% | 2111 |
|
|
2024
Q3 | $140K | Sell |
17,200
-28,800
| -63% | -$234K | ﹤0.01% | 2128 |
|
|
2024
Q2 | $294K | Sell |
46,000
-124,500
| -73% | -$796K | ﹤0.01% | 2073 |
|
|
2024
Q1 | $1.28M | Sell |
170,500
-112,400
| -40% | -$846K | ﹤0.01% | 1452 |
|
|
2023
Q4 | $2.62M | Sell |
282,900
-36,300
| -11% | -$336K | 0.01% | 1130 |
|
|
2023
Q3 | $3.23M | Sell |
319,200
-91,300
| -22% | -$924K | 0.01% | 939 |
|
|
2023
Q2 | $5.13M | Sell |
410,500
-7,300
| -2% | -$91.3K | 0.01% | 769 |
|
|
2023
Q1 | $4.88M | Buy |
417,800
+106,400
| +34% | +$1.24M | 0.01% | 819 |
|
|
2022
Q4 | $3.31M | Buy |
311,400
+21,500
| +7% | +$229K | 0.01% | 960 |
|
|
2022
Q3 | $2.81M | Buy |
289,900
+71,800
| +33% | +$696K | 0.01% | 1005 |
|
|
2022
Q2 | $3.16M | Buy |
218,100
+189,100
| +652% | +$2.74M | 0.01% | 977 |
|
|
2022
Q1 | $758K | Buy |
+29,000
| New | +$758K | ﹤0.01% | 1785 |
|
|
2021
Q2 | – | Sell |
-11,900
| Closed | -$557K | – | 2545 |
|
|
2021
Q1 | $557K | Buy |
+11,900
| New | +$557K | ﹤0.01% | 1969 |
|